Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Summit takes clinical trial participant search online

Hopes to broaden reach of its Duchenne muscular dystrophy study

Digital pharmaSummit is looking to reach potential clinical trial volunteers online via a new resource on utrophin modulation, whose potential as a treatment for Duchenne muscular dystrophy (DMD) the UK biopharma is investigating.

Utrophintrials.com provides information on utrophin and Summit's utrophin modulator clinical trials, including for its lead candidate the orphan drug ezutromid, which is currently in a phase IIa trial.

Glyn Edwards, Summit's chief executive officer, said: “We recognise the dedication and engagement of the DMD community in the search for solutions for this fatal muscle wasting disease, and with this website, seek to provide this community with access to important information about our utrophin modulator programme and clinical trials.

“We are committed to broadening our relationship with the DMD community as we advance ezutromid and other utrophin modulators, which may have the potential to treat all patients with DMD.”

A progressive muscle wasting disease, DMD affects around 50,000 boys and young men in the developed world and currently has no cure.

If Summit can bring ezutromid to market it will compete with PCT Therapeutics' Translarna, which was recommended by NICE in England and Wales earlier this year, and potentially Santhera Pharmaceuticals' delayed Raxone.

13th September 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics